Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line
Identifieur interne : 001F75 ( Istex/Curation ); précédent : 001F74; suivant : 001F76Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line
Auteurs : Beatriz Pardo [Espagne] ; María Angeles Mena [Espagne] ; Stanley Fahn [États-Unis] ; Justo García De Yébenes [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 1993.
English descriptors
- KwdEn :
Abstract
Levodopa, at concentrations of 0.25 × 10−4 M or larger, is toxic for the human neuroblastoma cell NB69. Toxicity is associated with high levels of quinones, increased activity of complex II‐III, and lack of changes of complex I of the mitochondrial respiratory chain. Deprenyl, which does not alter the production of quinones, has a partial protective effect. Tocopherol, 23 or 115 × 10−6 M, lacks significant preventive effect on levodopa toxicity, but ascorbic acid, 10−3 M, prevents levodopa toxicity and quinone formation. Deprenyl, 10−4 M, provides additional protection in cultures treated with levodopa and ascorbic acid. Our results indicate that ascorbic acid and deprenyl prevent levodopa neurotoxicity by unrelated mechanisms. Both compounds should be considered as complementary drugs to test for slowing the progression of Parkinson's disease.
Url:
DOI: 10.1002/mds.870080305
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001F75
Links to Exploration step
ISTEX:1FF422FA48EF46CEFE7C67CC412825F1778A4098Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line</title>
<author><name sortKey="Pardo, Beatriz" sort="Pardo, Beatriz" uniqKey="Pardo B" first="Beatriz" last="Pardo">Beatriz Pardo</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Research, Centro “Ramón y Cajal,” Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Research, Centro “Ramón y Cajal,” Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mena, Maria Angeles" sort="Mena, Maria Angeles" uniqKey="Mena M" first="María Angeles" last="Mena">María Angeles Mena</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Research, Centro “Ramón y Cajal,” Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Research, Centro “Ramón y Cajal,” Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Columbia University College of Physicians & Surgeons, New York, New York, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Columbia University College of Physicians & Surgeons, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo García" last="De Yébenes">Justo García De Yébenes</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Fundación Jiménez Díaz, Madrid, spain</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Espagne</country>
<wicri:regionArea>Department of Neurology, Fundación Jiménez Díaz, Madrid</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1FF422FA48EF46CEFE7C67CC412825F1778A4098</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1002/mds.870080305</idno>
<idno type="url">https://api.istex.fr/document/1FF422FA48EF46CEFE7C67CC412825F1778A4098/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F75</idno>
<idno type="wicri:Area/Istex/Curation">001F75</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line</title>
<author><name sortKey="Pardo, Beatriz" sort="Pardo, Beatriz" uniqKey="Pardo B" first="Beatriz" last="Pardo">Beatriz Pardo</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Research, Centro “Ramón y Cajal,” Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Research, Centro “Ramón y Cajal,” Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mena, Maria Angeles" sort="Mena, Maria Angeles" uniqKey="Mena M" first="María Angeles" last="Mena">María Angeles Mena</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Research, Centro “Ramón y Cajal,” Madrid, Spain</mods:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Research, Centro “Ramón y Cajal,” Madrid</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Columbia University College of Physicians & Surgeons, New York, New York, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Columbia University College of Physicians & Surgeons, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo García" last="De Yébenes">Justo García De Yébenes</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Fundación Jiménez Díaz, Madrid, spain</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Espagne</country>
<wicri:regionArea>Department of Neurology, Fundación Jiménez Díaz, Madrid</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1993">1993</date>
<biblScope unit="vol">8</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="278">278</biblScope>
<biblScope unit="page" to="284">284</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1FF422FA48EF46CEFE7C67CC412825F1778A4098</idno>
<idno type="DOI">10.1002/mds.870080305</idno>
<idno type="ArticleID">MDS870080305</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ascorbic acid</term>
<term>Levodopa</term>
<term>Neuroblastoma cell</term>
<term>Neurotoxicity</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Levodopa, at concentrations of 0.25 × 10−4 M or larger, is toxic for the human neuroblastoma cell NB69. Toxicity is associated with high levels of quinones, increased activity of complex II‐III, and lack of changes of complex I of the mitochondrial respiratory chain. Deprenyl, which does not alter the production of quinones, has a partial protective effect. Tocopherol, 23 or 115 × 10−6 M, lacks significant preventive effect on levodopa toxicity, but ascorbic acid, 10−3 M, prevents levodopa toxicity and quinone formation. Deprenyl, 10−4 M, provides additional protection in cultures treated with levodopa and ascorbic acid. Our results indicate that ascorbic acid and deprenyl prevent levodopa neurotoxicity by unrelated mechanisms. Both compounds should be considered as complementary drugs to test for slowing the progression of Parkinson's disease.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001F75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:1FF422FA48EF46CEFE7C67CC412825F1778A4098 |texte= Ascorbic acid protects against levodopa‐induced neurotoxicity on a catecholamine‐rich human neuroblastoma cell line }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |